Riordan Lewis & Haden | Equity Partners Acquires Nutritional Therapy Provider DCRX Infusion
23:27 EDT 2 Aug 2012 | Bio-Medicine
LOS ANGELES, Aug. 3, 2012 /- Riordan Lewis & Haden | Equity Partners (RLH) is pleased to announce its acquisition of DCRX Infusion, a leading provider of customized nutritional therapy to patients with end stage renal disease. DCRX, ba..
Original Article: Riordan Lewis & Haden | Equity Partners Acquires Nutritional Therapy Provider DCRX Infusion
More From BioPortfolio on "Riordan Lewis & Haden | Equity Partners Acquires Nutritional Therapy Provider DCRX Infusion"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
